© World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 9 Additional guidance for organizations performing in vivo bioequivalence studies

First Page		Document Content
Date: 2006-11-21 08:38:02 Pharmaceutical sciences Pharmaceutics Pharmaceuticals policy Food and Drug Administration Pharmacology Clinical trial Bioequivalence Good Laboratory Practice Good Clinical Practice Clinical research Research Pharmaceutical industry		© World Health Organization WHO Technical Report Series, No. 937, 2006 Annex 9 Additional guidance for organizations performing in vivo bioequivalence studies Add to Reading List Source URL: apps.who.int Download Document from Source Website File Size: 371,28 KB Share Document on Facebook

	TAMU Laboratory Safety Manual TEXAS A&M UNIVERSITY LABORATORY SAFETY MANUAL DocID: 1riAL - View Document
	The Agency for Medicinal Products and Medical Devices of the Republic of Slovenia has prepared the unofficial consolidated text for the Medicinal Products Act which includes:  Medicinal Products Act (Official Gazette DocID: 1r1yj - View Document
	ASTRAZENECA GLOBAL POLICY QUALITY AND REGULATORY COMPLIANCE WHO IS THIS POLICY FOR? DocID: 1qdzU - View Document
	Code of Practice for the Promotion of Animal Medicines Together with the Rules of Procedure for the DocID: 1q2Fu - View Document
	IRIS PHARMA FACT SHEET A GLOBAL SERVICE PROVIDER OF PRECLINICAL AND CLINICAL RESEARCH IN OPHTHALMOLOGY KEY FACTS COMPANY OVERVIEW DocID: 1pBzr - View Document